Skip to main content

Advertisement

The aptness of aptamers

Article metrics

  • 432 Accesses

Aptamers are nucleic acid ligands selected to interact with specific proteins with high affinity. In the September 5 Nature, Rusconi et al. describe the elegant design of a drug-antidote pair to control blood clotting using aptamer technology (Nature 2002, 419:90-94). They screened a nucleic-acid combinatorial library for aptamers specific for coagulation factor FIXa. They selected a high-affinity aptamer and demonstrated that it could inhibit FIXa activity and acted as an anti-coagulant. Rusconi et al. also created antidote oligonucleotides that blocked binding of the aptamer. The drug and antidote could effectively control clotting times in the plasma of patients with heparin-induced thrombocytopenia. This strategy presents a promising approach for the development of safe aptamer-antidote pairs as therapeutics.

References

  1. 1.

    Aptamers as potential nucleic acid pharmaceuticals.

  2. 2.

    Nature, [http://www.nature.com]

Download references

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Weitzman, J.B. The aptness of aptamers. Genome Biol 3, spotlight-20020911-01 (2002) doi:10.1186/gb-spotlight-20020911-01

Download citation

Keywords

  • Nucleic Acid
  • Thrombocytopenia
  • FIXa Activity
  • Blood Clotting
  • Specific Protein